questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Hydrocarbures cycliques
Hydrocarbures aromatiques
Dérivés du benzène
Composés benzhydryliques
Composés benzhydryliques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Intoxication
Tests de laboratoire
Analyse sanguine
Analyse urinaire
Évaluation clinique
Historique médical
Signes cliniques
Troubles neurologiques
Symptômes
5
Réactions cutanées
Démangeaisons
Troubles neurologiques
Convulsions
Difficultés respiratoires
Respiration rapide
Prévention
5
Prévention
Équipements de protection
Formations
Produits chimiques
Réglementations
Produits chimiques
Traitements
5
Intoxication
Charbon actif
Médicaments anticonvulsivants
Crises
Hydratation
Élimination des toxines
Hospitalisation
Complications
Complications
5
Complications
Neurologiques
Effets à long terme
Santé
Mesures de sécurité
Évitement
Facteurs de risque
5
Facteurs de risque
Travailleurs
Antécédents médicaux
Maladies respiratoires
Conditions environnementales
Ventilation
Habitudes de vie
Tabagisme
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Composés benzhydryliques : Questions médicales les plus fréquentes",
"headline": "Composés benzhydryliques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Composés benzhydryliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-14",
"dateModified": "2025-03-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Composés benzhydryliques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dérivés du benzène",
"url": "https://questionsmedicales.fr/mesh/D001555",
"about": {
"@type": "MedicalCondition",
"name": "Dérivés du benzène",
"code": {
"@type": "MedicalCode",
"code": "D001555",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diphénhydramine",
"alternateName": "Diphenhydramine",
"url": "https://questionsmedicales.fr/mesh/D004155",
"about": {
"@type": "MedicalCondition",
"name": "Diphénhydramine",
"code": {
"@type": "MedicalCode",
"code": "D004155",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "2,2'-Dichloro-4,4'-méthylènedianiline",
"alternateName": "Methylenebis(chloroaniline)",
"url": "https://questionsmedicales.fr/mesh/D008753",
"about": {
"@type": "MedicalCondition",
"name": "2,2'-Dichloro-4,4'-méthylènedianiline",
"code": {
"@type": "MedicalCode",
"code": "D008753",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Modafinil",
"alternateName": "Modafinil",
"url": "https://questionsmedicales.fr/mesh/D000077408",
"about": {
"@type": "MedicalCondition",
"name": "Modafinil",
"code": {
"@type": "MedicalCode",
"code": "D000077408",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Orphénadrine",
"alternateName": "Orphenadrine",
"url": "https://questionsmedicales.fr/mesh/D009966",
"about": {
"@type": "MedicalCondition",
"name": "Orphénadrine",
"code": {
"@type": "MedicalCode",
"code": "D009966",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115.600"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Composés benzhydryliques",
"alternateName": "Benzhydryl Compounds",
"code": {
"@type": "MedicalCode",
"code": "D001559",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Loyd V Allen",
"url": "https://questionsmedicales.fr/author/Loyd%20V%20Allen",
"affiliation": {
"@type": "Organization",
"name": "International Journal of Pharmaceutical Compounding. lallen@ijpc.com."
}
},
{
"@type": "Person",
"name": "Jonas Bresien",
"url": "https://questionsmedicales.fr/author/Jonas%20Bresien",
"affiliation": {
"@type": "Organization",
"name": "Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany. axel.schulz@uni-rostock.de."
}
},
{
"@type": "Person",
"name": "Jose M Goicoechea",
"url": "https://questionsmedicales.fr/author/Jose%20M%20Goicoechea",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Alexander Hinz",
"url": "https://questionsmedicales.fr/author/Alexander%20Hinz",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Moritz T Scharnhölz",
"url": "https://questionsmedicales.fr/author/Moritz%20T%20Scharnh%C3%B6lz",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Personalized oncology, ethics and adherence to NCCN guidelines.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39400758",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12032-024-02500-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Guideline adherence in ovarian cancer for surgical staging in the Netherlands.",
"datePublished": "2022-12-05",
"url": "https://questionsmedicales.fr/article/36270772",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/ijgc-2022-003666"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Dutch guideline to prevent perioperative pulmonal complications: how is the adherence?]",
"datePublished": "2022-10-20",
"url": "https://questionsmedicales.fr/article/36300494",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Guideline Adherence and Practice Patterns in the Management of Medullary Thyroid Cancer.",
"datePublished": "2022-09-30",
"url": "https://questionsmedicales.fr/article/36191377",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jss.2022.08.039"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adherence to national guidelines for colorectal, breast, and cervical cancer screenings in Japanese workplaces: a survey-based classification of enterprises' practices into \"overscreening,\" \"underscreening,\" and \"guideline-adherence screening\".",
"datePublished": "2024-08-15",
"url": "https://questionsmedicales.fr/article/39148101",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-024-19775-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composés benzhydryliques",
"item": "https://questionsmedicales.fr/mesh/D001559"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Composés benzhydryliques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Composés benzhydryliques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Composés benzhydryliques",
"description": "Comment diagnostiquer une intoxication aux composés benzhydryliques ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une surdose ?\nComment différencier les effets des composés benzhydryliques ?\nQuels signes cliniques sont associés à ces composés ?",
"url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Guideline+Adherence#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Composés benzhydryliques",
"description": "Quels sont les symptômes courants d'une exposition ?\nPeut-on avoir des réactions cutanées ?\nQuels effets neurologiques peuvent se manifester ?\nY a-t-il des symptômes respiratoires associés ?\nLes symptômes varient-ils selon la dose ?",
"url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Guideline+Adherence#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Composés benzhydryliques",
"description": "Comment prévenir l'exposition aux composés benzhydryliques ?\nY a-t-il des formations recommandées ?\nQuels sont les conseils de stockage sécuritaire ?\nComment sensibiliser le personnel aux risques ?\nQuelles sont les réglementations à suivre ?",
"url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Guideline+Adherence#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Composés benzhydryliques",
"description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes spécifiques existent-ils ?\nComment gérer les symptômes neurologiques ?\nQuelle est l'importance de l'hydratation ?\nQuand faut-il envisager une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Guideline+Adherence#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Composés benzhydryliques",
"description": "Quelles complications peuvent survenir après une exposition ?\nLes effets à long terme sont-ils possibles ?\nComment les complications sont-elles gérées ?\nY a-t-il des risques de cancer associés ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Guideline+Adherence#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Composés benzhydryliques",
"description": "Quels sont les principaux facteurs de risque d'exposition ?\nL'âge influence-t-il le risque d'effets ?\nLes antécédents médicaux jouent-ils un rôle ?\nLes conditions environnementales affectent-elles le risque ?\nLes habitudes de vie influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001559?mesh_terms=Guideline+Adherence#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux composés benzhydryliques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical et des tests de laboratoire spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'exposition ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses sanguines et urinaires peuvent détecter la présence de ces composés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surdose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent confusion, somnolence et troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Comment différencier les effets des composés benzhydryliques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation clinique complète et l'historique des médicaments sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à ces composés ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des anomalies neurologiques et des troubles cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une exposition ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vertiges et des maux de tête."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des réactions cutanées ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées et des démangeaisons peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels effets neurologiques peuvent se manifester ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de la coordination et des convulsions peuvent se produire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes respiratoires associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des difficultés respiratoires et une respiration rapide peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la dose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux composés benzhydryliques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection lors de la manipulation de ces substances."
}
},
{
"@type": "Question",
"name": "Y a-t-il des formations recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des formations sur la manipulation sécurisée des produits chimiques sont conseillées."
}
},
{
"@type": "Question",
"name": "Quels sont les conseils de stockage sécuritaire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Stocker dans des contenants étiquetés et dans des zones bien ventilées."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le personnel aux risques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Organiser des sessions d'information régulières sur les dangers des composés."
}
},
{
"@type": "Question",
"name": "Quelles sont les réglementations à suivre ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Respecter les réglementations locales et nationales sur la manipulation des produits chimiques."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend l'administration de charbon actif et une surveillance médicale."
}
},
{
"@type": "Question",
"name": "Des antidotes spécifiques existent-ils ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique pour les composés benzhydryliques."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes neurologiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments anticonvulsivants peuvent être administrés pour contrôler les crises."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'hydratation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation est cruciale pour aider à éliminer les toxines du corps."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hospitalisation est nécessaire en cas de symptômes graves ou de complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques et respiratoires peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les effets à long terme sont-ils possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme sur la santé peuvent survenir après une exposition prolongée."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien potentiel entre l'exposition et le cancer."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en respectant les mesures de sécurité et en évitant l'exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en laboratoire et ceux manipulant des produits chimiques sont à risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'effets ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales affectent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition dans des environnements mal ventilés augmente le risque."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme et l'alcoolisme peuvent exacerber les effets des composés."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/03/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
International Journal of Pharmaceutical Compounding. lallen@ijpc.com.
2 publications dans cette catégorie
Affiliations :
Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany. axel.schulz@uni-rostock.de.
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Affiliations :
Institut für Anorganische Chemie, Georg-August-Universität Göttingen, Tammannstraße 4, 37077, Göttingen, Germany.
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Affiliations :
Institut für Anorganische Chemie, Georg-August-Universität Göttingen, Tammannstraße 4, 37077, Göttingen, Germany.
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Affiliations :
Institut für Anorganische Chemie, Georg-August-Universität Göttingen, Tammannstraße 4, 37077, Göttingen, Germany.
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Affiliations :
Institut für Anorganische Chemie, Georg-August-Universität Göttingen, Tammannstraße 4, 37077, Göttingen, Germany.
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688, Krakow, Poland. Electronic address: a.rapacz@uj.edu.pl.
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Affiliations :
Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688, Krakow, Poland.
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Affiliations :
Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688, Krakow, Poland.
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688, Krakow, Poland.
Publications dans "Composés benzhydryliques" :
2 publications dans cette catégorie
Affiliations :
Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain.
Publications dans "Composés benzhydryliques" :
1 publication dans cette catégorie
Affiliations :
Department of Physiology, Sungkyunkwan University School of Medicine, Suwon, Korea.
Publications dans "Composés benzhydryliques" :
1 publication dans cette catégorie
Affiliations :
Department of Physiology, Sungkyunkwan University School of Medicine, Suwon, Korea.
Publications dans "Composés benzhydryliques" :
1 publication dans cette catégorie
Affiliations :
Department of Physiology, Sungkyunkwan University School of Medicine, Suwon, Korea.
Publications dans "Composés benzhydryliques" :
Successful personalized oncology today depends on clinicians taking advantage of the extensive, evidence-based information provided by the National Comprehensive Cancer Network (NCCN) Guidelines, whic...
Previous studies have shown low adherence to surgical staging guidelines in patients with clinical early-stage ovarian carcinoma. The aim of this study was to identify guideline adherence for surgical...
Patients with ovarian cancer and surgical staging registered in the Dutch Gynecological Oncology Audit between January 1, 2015 and December 31, 2019 in the Netherlands were included. Complete surgical...
604 patients underwent surgical staging, 365 (60%) underwent an incomplete staging procedure, 295 (81%) were registered with early-stage disease (International Federation of Gynecology and Obstetrics ...
Guideline adherence for staging was lower than expected and validation of data gave additional insights into the reasons that were contributing to incomplete surgical staging. Moreover, this analysis ...
Patients with a history of chronic obstructive pulmonary disease (COPD) or asthma undergoing surgery are at risk for developing postoperative pulmonary complications, associated with morbidity and mor...
Patients with a history of asthma and/or COPD who underwent non-thoracic surgery between January 2017 and July 2018 in our hospital, were included. Primary outcome was perioperative administration of ...
1,623 patients qualified for a preventative treatment. Overall, 653 patients (40%) received treatment according to protocol. The other 970 patients received no treatment (79%), another corticosteroid ...
The current guideline for prevention of postoperative pulmonary complications has not been implemented thoroughly at our hospital. The lack of adherence appears to be caused by lack in clarity in clin...
Little is known about nationwide practice patterns for the management medullary thyroid cancer (MTC) in relation to the 2015 American Thyroid Association guidelines and their impact on survival....
Using the Surveillance, Epidemiology, and End Results Program database (2000-2018), MTC treatment patterns were evaluated in terms of adherence to the 2015 American Thyroid Association guidelines acro...
A total of 3332 patients with MTC were identified. Of which, 53.8%, 33.2%, and 11.4% of patients had localized, regional, and distant disease, respectively. In patients with locoregional disease, the ...
The rate of guideline-concordant surgery for locoregional MTC increased after guideline publication in 2015, with an observed prolongment in OS and DSS. Chemotherapy use among patients with distant di...
Workplace cancer screening programs are determined as part of an employee's benefits package and health checkups are perceived positively. However, the current status of workplace cancer screening pro...
A cross-sectional study design was employed. Data were obtained from a survey conducted by the "Corporate Action to Promote Cancer Control" between November and December 2022 among registered partner ...
The guideline-adherence rates for colorectal, breast, and cervical cancer screenings in the workplace were 12.7%, 3.0%, and 8.8%, respectively. Enterprises had lower adherence to screening guidelines ...
Adherence to national guidelines for colorectal, breast, and cervical cancer screenings in the workplace was suboptimal among Japanese enterprises. Therefore, appropriate cancer screening measures and...
Despite the availability of evidence-based inflammatory bowel disease (IBD) guidelines, suboptimal care persists. There is little published research assessing barriers to IBD guideline adherence....
To identify barriers to IBD guideline adherence including gastroenterologists' knowledge and attitudes towards guidelines....
An online cross-sectional survey of 824 Australian gastroenterologists was conducted from April to August 2018, with 198 (24%) responses. A novel survey was developed that was informed by the theoreti...
Confidence in guideline recommendations was high; however, referral to them was low. The European Crohn's and Colitis Organisation guidelines were referred to most commonly (43.6%). In multivariate an...
Although gastroenterologists have high confidence in guidelines, they use them infrequently, primarily due to specifics being difficult to remember and lack of time. Self-reported confidence in an are...
Thromboembolic events are a common risk in adults with atrial fibrillation, those with previous cerebrovascular accidents and undergoing emergency or elective surgeries. The widespread availability of...
To improve the management of cancer related pain, the National Comprehensive Cancer Network (NCCN) publishes the Adult Cancer Pain guideline on an annual basis. However, a large majority of oncology p...
The spleen is responsible for blood filtration and mounting an immune response against pathogens. In some people the spleen must be surgically removed because of traumatic events or oncological and he...
Traumatic brain injury (TBI) is a leading cause of death and morbidity worldwide. Evidence-based guidelines for managing severe TBI have been available for over 25 years. However, adherence to guideli...
A structured literature search was conducted using the MEDLINE...
Nine cohort studies were identified that fulfilled the inclusion criteria and answered the clinical question. A review of these papers was conducted....
Mortality after severe TBI improves with increasing adherence to evidence-based guidelines in both adults and children. The evidence also suggests that compliance with guideline recommendations result...